Um, no. No way in heck they raise $1Billion and only give away 300mil shares. Are you guys reading the terms of these financing deals? Are you aware of the severe strain that the high yield lending markets are under at this time?
I could say more, but why bother? No one seems to care about the financials. Clearly, very few are reading the SEC filings.
I'm ecstatic everyone is already rich and the stock is one announcement away from $45+. Yippee!
Personally, I'm much more cautious after seeing how management operates. NP doesn't know how to provide guidance with a buffer. I don't care about the BLA delays. The FDA has changed the target a few times and the ball is in Amarex's court. I care about how the company guides investors concerning the delays. We shouldn't have to catch a little comment from NP in a local tv segment stating he expects it by the end of April now. I don't care that much about these small financing deals. They have to be done to keep the lights on & apparently these lousy terms are the best they can get. But I care that the CFO is allowing PR's to go out that don't include all the major financing terms. Unacceptable & unnecessary.
I've noticed a lot of tidbits that seem to fall into the "what the heck happened..." (Chinese LOI; what's the real story behind Samsung supposedly fronting $50mil of inventory; now the gov't grant and the emergency FDA approval request). I hope all of them come true, but I'm starting to get cautious as the list grows. It almost seems like they're purposely trying to manipulate the stock higher. Now that I've seen the 10Q, I could understand why. Also, IMO, the market seems fatigued from all the the PR's. They don't seem to be providing the same trading impact. Personally, I've never seen a company issue this many PR's in 30+ yrs of being in the markets.
I always hope for the best. But my head is always focused on the risks.
We'll see! The next few weeks are going to be interesting.
Time will tell.
I could say more, but why bother? No one seems to care about the financials. Clearly, very few are reading the SEC filings.
I'm ecstatic everyone is already rich and the stock is one announcement away from $45+. Yippee!
Personally, I'm much more cautious after seeing how management operates. NP doesn't know how to provide guidance with a buffer. I don't care about the BLA delays. The FDA has changed the target a few times and the ball is in Amarex's court. I care about how the company guides investors concerning the delays. We shouldn't have to catch a little comment from NP in a local tv segment stating he expects it by the end of April now. I don't care that much about these small financing deals. They have to be done to keep the lights on & apparently these lousy terms are the best they can get. But I care that the CFO is allowing PR's to go out that don't include all the major financing terms. Unacceptable & unnecessary.
I've noticed a lot of tidbits that seem to fall into the "what the heck happened..." (Chinese LOI; what's the real story behind Samsung supposedly fronting $50mil of inventory; now the gov't grant and the emergency FDA approval request). I hope all of them come true, but I'm starting to get cautious as the list grows. It almost seems like they're purposely trying to manipulate the stock higher. Now that I've seen the 10Q, I could understand why. Also, IMO, the market seems fatigued from all the the PR's. They don't seem to be providing the same trading impact. Personally, I've never seen a company issue this many PR's in 30+ yrs of being in the markets.
I always hope for the best. But my head is always focused on the risks.
We'll see! The next few weeks are going to be interesting.
Time will tell.
3
2
